Cargando…

Pre-treatment minority HIV-1 drug resistance mutations and long term virological outcomes: is prediction possible?

BACKGROUND: Although the use of highly active antiretroviral therapy in HIV positive individuals has proved to be effective in suppressing the virus to below detection limits of commonly used assays, virological failure associated with drug resistance is still a major challenge in some settings. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mzingwane, M. L., Tiemessen, C. T., Richter, K. L., Mayaphi, S. H., Hunt, G., Bowyer, S. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062819/ https://www.ncbi.nlm.nih.gov/pubmed/27733203 http://dx.doi.org/10.1186/s12985-016-0628-x

Ejemplares similares

Detection and molecular characterization of urinary tract HIV-1 populations
por: Mzingwane, M. L., et al.
Publicado: (2019)

Assessment of minority frequency pretreatment HIV drug-resistant variants in pregnant women and associations with virologic non-suppression at term
por: Boyce, Ceejay L., et al.
Publicado: (2022)

A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation
por: Violari, Avy, et al.
Publicado: (2019)

Evaluation of the HIV-1 Polymerase Gene Sequence Diversity for Prediction of Recent HIV-1 Infections Using Shannon Entropy Analysis
por: Nkone, Paballo, et al.
Publicado: (2022)

Virologic Response to Very Early HIV Treatment in Neonates
por: Shiau, Stephanie, et al.
Publicado: (2021)

Deep sequencing of the HIV-1 polymerase gene for characterisation of cytotoxic T-lymphocyte epitopes during early and chronic disease stages
por: Nkone, Paballo, et al.
Publicado: (2022)

Correction to: Deep sequencing of the HIV-1 polymerase gene for characterisation of cytotoxic T-lymphocyte epitopes during early and chronic disease stages
por: Nkone, Paballo, et al.
Publicado: (2022)

Correlation of HIV-1 drug resistant mutations and virologic failure
por: Makwaga, Olipher, et al.
Publicado: (2021)

Minor Protease Inhibitor Mutations at Baseline Do Not Increase the Risk for a Virological Failure in HIV-1 Subtype B Infected Patients
por: Scherrer, Alexandra U., et al.
Publicado: (2012)

Clinical impact of ultra deep versus Sanger sequencing detection of minority mutations on HIV-1 drug resistance genotype interpretation after virological failure
por: Mohamed, Sofiane, et al.
Publicado: (2014)

Long‐term clinical, virological and immunological outcomes following planned treatment interruption in HIV‐infected children
por: Freguja, R, et al.
Publicado: (2020)

Long-term clinical, immunologic and virologic impact of glucocorticoids on the chronic phase of HIV infection
por: Andrieu, Jean-Marie, et al.
Publicado: (2004)

Temporary Treatment during Primary HIV Infection Does Not Affect Virologic Response to Subsequent Long-Term Treatment
por: Grijsen, Marlous L., et al.
Publicado: (2014)

Minor HIV-1 Variants with the K103N Resistance Mutation during Intermittent Efavirenz-Containing Antiretroviral Therapy and Virological Failure
por: Delobel, Pierre, et al.
Publicado: (2011)

Virological Failure in HIV to Triple Therapy With Dolutegravir-Based Firstline Treatment: Rare but Possible
por: Pena, M J, et al.
Publicado: (2018)

Epidemiological features, therapeutic strategies and long-term immunological outcomes in virologically suppressed HIV+ very late presenters
por: Martinelli, L, et al.
Publicado: (2010)

Long-term virological suppression on first-line efavirenz + tenofovir + emtricitabine/lamivudine for HIV-1
Publicado: (2019)

Long-term outcome of lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients
por: Maggiolo, Franco, et al.
Publicado: (2022)

Long-term virological outcome in chronic hepatitis B patients with a partial virological response to entecavir
por: Jo, Yu Jung, et al.
Publicado: (2015)

A minority of tuberculosis cases occurring during HIV care is possibly preventable
por: Skeie, L, et al.
Publicado: (2010)

Prevalence of Premalignant Cervical Lesions in Women With a Long-term Nonprogressor or HIV Controller Phenotype
por: McLeod, Katherine E., et al.
Publicado: (2014)

Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
por: Abdissa, Alemseged, et al.
Publicado: (2014)

Comparable carotid intima-media thickness among long-term virologically suppressed individuals with HIV and those without HIV in Thailand
por: Putcharoen, Opass, et al.
Publicado: (2019)

Virological Failure and HIV-1 Drug Resistance Mutations among Naive and Antiretroviral Pre-Treated Patients Entering the ESTHER Program of Calmette Hospital in Cambodia
por: Barennes, Hubert, et al.
Publicado: (2014)

Long-term virological outcome in children on antiretroviral therapy in the UK and Ireland
por: Duong, Trinh, et al.
Publicado: (2014)

Reduction in terminally differentiated T cells in virologically controlled HIV-infected aging patients on long-term antiretroviral therapy
por: Behrens, Nicole E., et al.
Publicado: (2018)

Adherence monitoring methods to measure virological failure in people living with HIV on long-term antiretroviral therapy in Uganda
por: Okoboi, Stephen, et al.
Publicado: (2022)

Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial
por: Szubert, Alexander J., et al.
Publicado: (2017)

Alternative methods to analyse the impact of HIV mutations on virological response to antiviral therapy
por: Wittkop, Linda, et al.
Publicado: (2008)

Prevalence and Impact of Minority Variant Drug Resistance Mutations in Primary HIV-1 Infection
por: Stekler, Joanne D., et al.
Publicado: (2011)

Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan children
por: Kityo, Cissy, et al.
Publicado: (2017)

Patterns of acquired HIV-1 drug resistance mutations and predictors of virological failure in Moshi, Northern Tanzania
por: Mziray, Shabani Ramadhani, et al.
Publicado: (2020)

Drug resistance outcomes of long-term ART with tenofovir disoproxil fumarate in the absence of virological monitoring
por: Villa, Giovanni, et al.
Publicado: (2018)

Virological investigation of fatal rabies in a minor bitten by a mongrel in Nigeria
por: Tekki, Ishaya Sini, et al.
Publicado: (2021)

HIV-1/2 differentiation in a South African public laboratory
por: Mafuyeka, Rendani T., et al.
Publicado: (2021)

Clinical Outcome of HIV-Infected Patients with Sustained Virologic Response to Antiretroviral Therapy: Long-Term Follow-Up of a Multicenter Cohort
por: Gutierrez, Félix, et al.
Publicado: (2006)

Lower pre-ART intra-participant HIV-1 pol diversity may not be associated with virologic failure in adults
por: Kearney, Mary F., et al.
Publicado: (2018)

Applications of Deep Mutational Scanning in Virology
por: Burton, Thomas D., et al.
Publicado: (2021)

Antiretroviral Genotypic Resistance Mutations in HIV-1 Infected Korean Patients with Virologic Failure
por: Chin, Bum Sik, et al.
Publicado: (2009)

Pre-treatment HIV-drug resistance associated with virologic outcome of first-line NNRTI-antiretroviral therapy: A cohort study in Kenya
por: Beck, Ingrid A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2irih69dgue73pc8s7vie21cm4